Financials

News Discussions Technicals Forecast Seasonals

389650 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Nextbiomedical Co. Ltd. engages in the development of therapeutics based on polymer and drug delivery system technologies. Its products include Nexpowder: Hemostatic Systems for Endoscopy, Nexsphere: Resorbable Gelatin Microspheres for Tailored Embolization, Nexsphere-F: Fast-Resorbable Gelatin Microspheres for Musculoskeletal Embolization and NexGel: Resorbable Gelatin Microparticle for Embolization. The company was founded on August 1, 2014 and is headquartered in Incheon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

389650 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company